Trial on The Efficacy of Hypertonic Saline on Non-CF CSLD.
Status:
Recruiting
Trial end date:
2023-02-28
Target enrollment:
Participant gender:
Summary
To determine the efficacy of nebulized 5% hypertonic saline on cough severity and quality of
life, in children with non-CF CSLD.
Secondary Aims:
To determine the:
1. Efficacy of nebulized 5% hypertonic saline on airway microbiome, pulmonary exacerbation
rate, healthcare utilization, and rescue antibiotics.
2. Efficacy of nebulized 5% hypertonic saline on lung function
3. Adverse effects of nebulized 5% hypertonic saline in children